Craig-Hallum Maintains Buy on Biote, Lowers Price Target to $8

Benzinga · 03/13 13:37
Craig-Hallum analyst Alex Fuhrman maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $12 to $8.